600079 人福医药
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额845,8771,967,2502,441,0712,178,8112,089,806
投资活动产生之现金流量净额(582,242)(1,224,718)1,226,790(1,420,209)301,676
筹资活动产生之现金流量净额(740,197)(2,105,567)(4,244,942)(913,998)200,130
汇率变动对现金及现金等价物的影响8,78416,29948,452(24,956)(105,992)
现金及现金等价物净增加/(减少)(467,778)(1,346,737)(528,629)(180,353)2,485,620
期初现金及现金等价物余额2,990,4454,337,1814,865,8115,046,1632,560,543
期末现金及现金等价物余额2,522,6662,990,4454,337,1814,865,8115,046,163